Home › Funds › RTW INVESTMENTS, LP › URGN

RTW INVESTMENTS, LP position in URGN

UROGEN PHARMA LTD · Health Care

RTW INVESTMENTS, LP reported holding 4,543,895 shares of URGN (UROGEN PHARMA LTD) in its Q3 2026 13F filing — a position valued at US$184.6M, representing 1.86% of its reported portfolio and ranking #18 among its reported holdings. RTW INVESTMENTS, LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.54M sh
Reported value held$184.62M
Portfolio Weight1.86%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's URGN position evolved

RTW INVESTMENTS, LP first disclosed a stake in URGN in Q3 2023 at 857,464 shares (US$12.0M). The position peaked in Q3 2026 at 4,543,895 shares, worth US$184.6M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,543,895 shares valued at US$184.6M. Notable position changes include a 101% increase in Q4 2023 (shares were roughly flat over the following quarter), a 89% increase in Q1 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 857.46K $12.01M New
Q4 2023 1.73M $25.90M Add
Q1 2024 3.26M $48.86M Add
Q2 2024 3.56M $59.69M Add
Q3 2024 3.79M $48.10M Add
Q4 2024 3.83M $40.84M Add
Q1 2025 3.83M $42.41M Hold
Q2 2025 4.54M $62.25M Add
Q3 2025 4.54M $90.65M Hold
Q4 2025 4.54M $106.42M Hold
Q1 2026 4.54M $81.70M Hold
Q2 2026 4.54M $167.22M Hold
Q3 2026 4.54M $184.62M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About URGN and 13F data

URGN (UROGEN PHARMA LTD) is a Health Care company. 46 other funds we track also report a position in URGN — the largest reported positions include Kynam Capital Management, LP (US$98.9M), Jefferies Financial Group Inc. (US$89.4M), ACORN CAPITAL ADVISORS, LLC (US$67.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding URGN

All URGN fund holders →

FAQ

How long has RTW INVESTMENTS, LP held URGN?

RTW INVESTMENTS, LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RTW INVESTMENTS, LP's current position in URGN?

As of Q3 2026, RTW INVESTMENTS, LP holds 4.54M shares of URGN (UROGEN PHARMA LTD), valued at $184.62M, representing 1.86% of its reported portfolio and ranking #18.

Has RTW INVESTMENTS, LP been buying or selling URGN?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in URGN. The position peaked in Q3 2026 at 4.54M shares.

Which other funds hold URGN?

Other major institutional holders of URGN include Kynam Capital Management, LP, Jefferies Financial Group Inc., ACORN CAPITAL ADVISORS, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.